Two of the four experimental COVID-19 vaccines developed by Pfizer Inc
and BioNTech using the BNT162 mRNA-based vaccine program received Fast
Track designation from the US Food and Drug Administration (USFDA).
The two most advanced vaccine candidates, BNT162b1 and BNT162b2, are
currently being tested in ongoing Phase 1/2 clinical studies in
Germany and the US. […]
The post Vaccine Candidates By Pfizer & BioNTech Gets Fast Track
Designation appeared first on Rasayanika .
https://www.rasayanika.com/2020/07/16/covid-19-vaccine-by-pfizer-and-biontech-received-usfda-fast-track/
News,Uncategorized
No comments:
Post a Comment